(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Protein Labeling Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global protein labeling market is experiencing rapid expansion, supported by increased investment in proteomics and genomics research, continued advances in labeling technologies, and growing demand for high-performance analytical tools. The market is projected to rise from $2.84 billion in 2025 to $3.13 billion in 2026, representing a compound annual growth rate (CAGR) of 10.1%.
By 2030, the protein labeling market is expected to reach $4.89 billion, expanding at a CAGR of 11.8% from 2026. This growth reflects the increasing use of protein labeling products across biomedical research, drug discovery, diagnostics, fluorescence microscopy, cell-based assays, immunological techniques, mass spectrometry, and protein microarrays.
Historical market growth has been supported by rising demand for cell-based assays, broader adoption of enzyme-conjugated labeling techniques, and increased proteomics research. The transition from traditional fluorescent dyes to more specialized and sensitive labeling solutions has also helped research organizations improve protein detection, identification, and analysis.
During the forecast period, the development of novel fluorophore probes is expected to create significant protein labeling market opportunities. Other growth factors include the expanding use of recombinant and modified proteins, wider adoption of automated labeling platforms, and greater integration of protein labeling with mass spectrometry and high-throughput assays. Demand for fluorescent and chemiluminescent labels is also increasing as laboratories seek stronger signals, improved stability, and greater accuracy in complex research workflows.
Higher research and development expenditure is strengthening demand for protein labeling reagents, probes, enzymes, and related technologies. In the United Kingdom, government net expenditure on research and development increased from £16.1 billion ($20.45 billion) in 2022 to £17.4 billion ($22.1 billion) in 2023, according to the Office for National Statistics. This represented an 8.2% increase and highlights the broader funding environment supporting proteomics, genomics, life sciences, and biomedical innovation.
Product innovation remains a central protein labeling market trend. Companies are developing advanced antibody-conjugation technologies designed to improve detection sensitivity, support multiplexing, simplify laboratory workflows, and enhance assay performance. In January 2025, Bio-Rad Laboratories introduced its TrailBlazer Tag and TrailBlazer StarBright Dye Label Kits. The kits enable efficient antibody conjugation for advanced flow cytometry and imaging applications while supporting clearer signals and complex multicolor experiments.
Strategic acquisitions are also reshaping the competitive environment. In December 2023, Danaher Corporation acquired Abcam plc for an undisclosed amount. The transaction was intended to broaden Danaher's life sciences portfolio, strengthen its research and development capabilities, improve access to antibody products, and reinforce its position within the global life sciences and diagnostics sector. Abcam provides protein labeling services and research tools used across multiple scientific applications.
Key market trends expected to influence future growth include:
Increasing adoption of in vitro and in vivo protein labeling techniques Rising use of monoclonal antibodies in immunological applications Expansion of fluorescence microscopy and cell-based assay workflows Greater demand for automated, scalable, and high-throughput labeling platforms Continued development of brighter and more photostable fluorescent dyes Growing integration of protein labeling with mass spectrometry
North America was the largest region in the protein labeling market in 2025. The broader market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.
Markets Covered:
1) By Product: Reagents; Protein; Enzymes; Probes/ Tags; Monoclonal Antibodies
2) By Labeling Method: In-vitro Labeling; In-vivo Labeling
3) By Application: Cell Based-Assay; Fluorescence Microscopy; Immunological Techniques; Mass Spectrometry; Protein Micro Assay
Subsegments:
1) By Reagents: Fluorescent Dyes; Enzyme Labels; Chemiluminescent Reagents; Radioactive Labels
2) By Protein: Recombinant Proteins; Native Proteins; Modified Proteins
3) By Enzymes: Alkaline Phosphatase; Horseradish Peroxidase; Other Enzymatic Labels
4) By Probes Or Tags: Biotin Labels; Antibody Tags; Fluorophore Probes; Affinity Tags
5) By Monoclonal Antibodies: Primary Monoclonal Antibodies; Secondary Monoclonal Antibodies; Conjugated Monoclonal Antibodies
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment